FORMULATION AND EVALUATION OF MATRIX TABLET LOADED LYOPHILIZED BENIDIPINE Authors: Patel Sejal P* And Patel Anita P
ABSTRACT
An antihypertensive drug, Benidipine (BND) is Biopharmaceutical Classification System Class-II drug
having low solubility and high permeability and has lower bioavailability. The present study describes the
preparation of matrix tablet from lyophilized BND nanoparticles as lyophilization technique is used in
order to improve the dissolution and oral bioavailability of the drugs with poor solubility and high
permeability, matrix tablet was formulated to achieve extended drug release and to study its drug release
pattern as well. BND has mean half-life 5.3 hr and requires frequent dosing every 5-6 hr to maintain
optimal relive and used orally in the treatment of hypertension and angina pectoris, but this frequent
administration produces side effects like dizziness and headache. So in present study we have achieved
extended drug release for time up to 25 hr for treatment of hypertension, for continuous 24 hr control of
blood pressure (BP), by using polymers HPMC K4, chitosan, MCC, magnesium stearate, lactose and talc
in order to prepare the suitable formulation. Matrix tablets of lyophilized BND nanoparticles was
formulated using 32
factorial design in order to study the effect of independent variables X1 and X2 (i.e.
amount of HPMC K4 and Chitosan respectively) on dependent variable (i.e. % drug release in 10 hr (Q10)
and time require for 80% drug release (T80)) to evaluate extended drug release. The tablets were prepared
by direct compression method. In-vitro drug release of different formulations was carried out under
stimulated gastric and intestinal condition to achieve optimized drug release. Optimized batch F5 has
achieved 99% drug release in 25 hr. The physiochemical characterizations of all prepared formulations were found to be satisfactory. Fourier transform infrared spectroscopy (FTIR) study of optimized F5
batch was performed to study any interaction of BND with polymer.
Keywords: Benidipine, Bioavailability, lyophilization, hypertension, direct compression method,
Matrix Tablet
Publication date: 01/07/2022 https://ijbpas.com/pdf/2022/July/MS_IJBPAS_2022_6194.pdfDownload PDFhttps://doi.org/10.31032/IJBPAS/2022/11.7.6194